Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Bonehead Teva and Tilray are working with Syqe do some DD !

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Dec 29, 2021 3:30pm

119 Views

Post# 34268687

RE:RE:Bonehead Teva and Tilray are working with Syqe do some DD !

Thanks more swearing , grow up already, you wouldn't get all defensive if Tetra was going to ever become anything on its own, you were probably pumping Tilray at 300.00 which is now at 10.00 scammer.So you know Syqe has measured doses and will be prescribed in Canada years before Tetra has anything , you can't run a company on fairy dust and unicorn farts for ever.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing